​

Anavex Life Sciences Ownership | Who Owns Anavex Life Sciences?

OverviewForecastFinancialsChartTranscripts

Anavex Life Sciences Ownership Summary

Anavex Life Sciences is owned by 43.54% institutional investors, 3.12% insiders, and 53.35% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.55% of AVXL shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.11% of its assets in Anavex Life Sciences shares.

AVXL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAnavex Life Sciences43.54%3.12%53.35%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de7.61M8.55%$23.36M
Blackrock6.39M7.75%$26.97M
Vanguard group5.03M5.90%$17.90M
State street4.51M5.07%$13.85M
Two sigma investments, lp3.25M3.65%$9.97M
Geode capital management2.19M2.46%$6.72M
Susquehanna group, llp995.66K1.12%$3.06M
Summit financial940.46K1.06%$2.89M
Goldman sachs group804.43K0.90%$2.47M
Two sigma advisers, lp758.50K0.89%$6.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pvg asset management216.29K1.64%$770.01K
Sheets smith investment management135.95K0.78%$1.21M
Allsquare wealth management52.38K0.27%$482.97K
Watts gwilliam26.00K0.07%$349.96K
October effect15.25K0.05%$46.82K
Hayek kallen investment management47.11K0.05%$145.00K
180 wealth advisors119.47K0.04%$366.79K
Sheets smith wealth management117.81K0.04%$361.66K
Quadrant capital group141.000.04%$48.97M
Summit financial940.46K0.04%$2.89M

Top Buyers

HolderShares% AssetsChange
Two sigma investments, lp3.25M0.01%1.59M
Hrt financial lp657.88K0.01%657.88K
Vanguard fiduciary trust647.17K0.00%647.17K
Aqr capital management756.79K0.00%606.98K
Susquehanna group, llp995.66K0.00%556.16K

Top Sellers

HolderShares% AssetsChange
Wealthgarden f.s.---910.48K
Nwam---870.80K
Jupiter asset management---804.64K
Pier capital---415.91K
Essential planning, llc.---413.09K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp657.88K0.01%657.88K$2.02M
Vanguard fiduciary trust647.17K0.00%647.17K$1.99M
Sheets smith investment management135.95K0.78%135.95K$1.21M
Ieq capital69.10K0.00%69.10K$212.14K
Lexaurum advisors67.45K0.03%67.45K$207.07K

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Nelson, van denburg & campbell wealth management group-14.00
Stephens consulting-40.00
Pinnacle wealth planning services-43.00
Bay harbor wealth management-70.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026192-2.54%38,759,8962.56%432.42%10917.20%46-13.21%
Dec 31, 202563-68.34%8,715,170-73.43%100.69%29-67.42%21-56.25%
Sep 30, 202582-56.61%9,007,990-72.28%100.73%29-68.48%23-34.29%
Jun 30, 2025184-6.60%32,327,9853.05%372.78%89-11.00%35-23.91%
Mar 31, 20253-98.38%406,643-98.62%-0.04%2-98.04%--100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF2.88M3.11%-29.77K
Vanguard US Total Market Shares ETF2.53M2.98%-
Vanguard Total Stock Mkt Idx Inv2.73M2.95%-
iShares Russell 2000 ETF2.05M2.22%17.30K
SPDR® S&P Biotech ETF1.12M1.31%2.50K
Vanguard Institutional Extnd Mkt Idx Tr1.05M1.13%-
Invesco Biotechnology & Genome ETF764.01K0.89%-2.40K
Fidelity Small Cap Index820.51K0.89%7.64K
iShares Russell 2000 Growth ETF725.30K0.78%1.87K
iShares Biotechnology ETF658.72K0.71%4.17K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 14, 2024Donhauser Peter D.O.-Buy$10.32K
May 15, 2024Thomas Steffen-Buy$22.60K
Mar 28, 2024MISSLING CHRISTOPHER U President and CEOSell$374.97K
Jun 28, 2023MISSLING CHRISTOPHER U President and CEOSell$2.14M
May 25, 2022Skarpelos Athanasios Sell$453.00K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--

AVXL Ownership FAQ

Who Owns Anavex Life Sciences?

Anavex Life Sciences shareholders are primarily institutional investors at 43.54%, followed by 3.12% insiders and 53.34% retail investors. The average institutional ownership in Anavex Life Sciences's industry, Biotech Stocks , is 35.75%, which Anavex Life Sciences exceeds.

Who owns the most shares of Anavex Life Sciences?

Anavex Life Sciences’s largest shareholders are Blackrock funding, inc. /de (7.61M shares, 8.55%), Blackrock (6.39M shares, 7.75%), and Vanguard group (5.03M shares, 5.90%). Together, they hold 22.19% of Anavex Life Sciences’s total shares outstanding.

Does Blackrock own Anavex Life Sciences?

Yes, BlackRock owns 7.75% of Anavex Life Sciences, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.97M$. In the last quarter, BlackRock decreased its holdings by -254K shares, a -3.82% change.

Who is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested?

Pvg asset management is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested, with 1.64% of its assets in 216.3K Anavex Life Sciences shares, valued at 770.01K$.

Who is the top mutual fund holder of Anavex Life Sciences shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Anavex Life Sciences shares, with 3.11% of its total shares outstanding invested in 2.88M Anavex Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools